On ECHEMI
Home > Drugs > Amoxicillin and Clavulanate Potassium Granules

Amoxicillin and Clavulanate Potassium Granules

Function and Efficacy

1This product is a compound preparation of amoxicillin and potassium clavulanate. Amoxicillin is a broad-spectrum penicillin antibiotic. Potassium clavulanate itself has only weak antibacterial activity, but has a strong broad-spectrum beta-lactamase inhibitory effect. The combination of the two can protect amoxicillin from beta-lactamase hydrolysis. 2The antibacterial spectrum of this product is the same as that of amoxicillin, and has been expanded. It has a good effect on enzyme-producing Staphylococcus aureus, Staphylococcus epidermidis, coagulase-negative Staphylococci and enterococci. It also has good antibacterial activity against some beta-lactamase-producing Enterobacteriaceae, Haemophilus influenzae, Moraxella catarrhalis, Bacteroides fragilis, etc. This product has no effect on methicillin-resistant Staphylococcus aureus and Enterobacter, Enterobacteriaceae and Pseudomonas that produce chromosome-mediated type I enzymes.

Ingredients

Amoxicillin, Clavulanate Potassium

Name Description Content CAS NO. Manufacturer
AmoxicillinIngredients

Amoxicillin is a broad-spectrum penicillin antibiotic, and potassium clavulanate can protect it from hydrolysis by β-lactamase. It has a good effect on enzyme-producing Staphylococcus aureus, Staphylococcus epidermidis, coagulase-negative Staphylococci and enterococci, and also has good antibacterial activity against certain β-lactamase-producing Enterobacteriaceae, Haemophilus influenzae, Moraxella catarrhalis, Bacteroides fragilis, etc.

More
26787-78-0 30
Potassium clavulanateIngredients

It has only weak antibacterial activity itself, but has a strong broad-spectrum β-lactamase inhibitory effect and can protect amoxicillin from β-lactamase hydrolysis.

More
61177-45-5 27

Appearance

This product is white or light yellow granules with aromatic smell and sweet taste.

Indication

This product is suitable for various infections caused by sensitive bacteria, such as: 1. Upper respiratory tract infections: sinusitis, tonsillitis, pharyngitis, otitis media, etc. 2. Lower respiratory tract infections: acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis combined with infection, etc. 3. Urinary system infections: cystitis, urethritis, pyelonephritis, prostatitis, pelvic inflammatory disease, gonococcal urinary tract infection and soft chancroid, etc. 4. Skin and soft tissue infections: furuncle, abscess, cellulitis, wound infection, intra-abdominal sepsis, etc. 5. Other infections: osteomyelitis, sepsis, peritonitis and postoperative infection, etc.

Usage and Dosage

Oral: Adults and children over 12 years old, 2 packets each time, three times a day. Children aged 7 to 12 years old, 1.5 packets each time, three times a day. Children aged 1 to 7 years old, 1 packet each time, three times a day. Children aged 3 months to 1 year old, half a packet each time, three times a day. In case of severe infection, the dose can be doubled or as directed by the doctor. The continuous treatment period shall not exceed 14 days without reexamination.

Adverse Reactions

1. A small number of patients may experience mild gastrointestinal side effects such as nausea, vomiting and diarrhea. If these side effects occur, they can be restored to normal by taking the medicine at the beginning of a meal. 2. Urticaria and morbilliform rash are occasionally seen. If urticaria and severe morbilliform rash occur, the use of this product should be stopped. 3. Temporary liver function abnormalities may be seen in a very small number of patients.

Precautions

Contraindicated in patients allergic to penicillin.

Special Population Medication

Precautions for children: The safety and effectiveness of this product for infants under 3 months old have not been determined. Precautions for pregnancy and lactation: Since oral ampicillin antibiotics have a certain impact on absorption during pregnancy, the decision should be made after a doctor's study. In addition, this product can be excreted through breast milk. Therefore, breastfeeding women should be cautious. Precautions for the elderly: It is not clear yet.

Drug Interactions

1. Aspirin, indomethacin, phenylbutazone, and sulfonamides can reduce the excretion of this product in the renal tubules, thereby increasing the blood concentration of this product, prolonging the blood elimination half-life (t1/2beta;), and possibly increasing toxicity. 2. When this product is used in combination with allopurinol, the incidence of rash increases significantly, so it should be avoided. 3. This product should not be used in combination with acetaldehyde dehydrogenase inhibitors such as disulfiram. 4. When this product is used in combination with chloramphenicol for bacterial meningitis, the incidence of long-term sequelae is higher than when either is used alone. 5. This product can stimulate estrogen metabolism or reduce its enterohepatic circulation, thereby reducing the effectiveness of oral contraceptives. 6. Antibiotics such as chloramphenicol, erythromycin, tetracyclines, and antibacterial drugs such as sulfonamides can interfere with the bactericidal activity of this product, so it should not be used in combination with this product, especially in the treatment of meningitis or severe infections that urgently require bactericidal drugs. 7. This product can enhance the effect of warfarin. 8Aminoglycoside antibiotics can generally enhance the in vitro bactericidal effect of this product on Enterococcus faecalis at sub-inhibitory concentrations. 9Since the absorption of this product in the gastrointestinal tract is not affected by food, it can be taken on an empty stomach or after a meal, and can be taken with milk and other foods; taking it with food can reduce gastrointestinal reactions.

Storage

Keep in a dark place, sealed and protected from light. Valid for two years.

Packaging Specification

156.25 mg (C16H19N3O5S125 mg and C8H9NO531.25 mg)

Validity Period

24 months

Manufacturer

Sichuan YIKE Pharmaceutical Co., Ltd.

  • Founded in:

    1999-02-03
  • Address:

    No. 2, Section 4, Zhongshan Avenue South, Guanghan City, Sichuan Province
  • Tax NO.:

    915106817118139642
  • Registered Funds:

    93.41 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.